Miricor Enterprises Holdings Ltd (1827) AI Stock Analysis

• Market Cap: HK$368.00M
• Dividend Yield: N/A
• Average Volume (3M): 4.67K
• Price to Earnings (P/E): 34.7
• Beta (1Y): -0.09
• Revenue Growth: -20.59%
• EPS Growth: N/A
• Country: HK
• Employees: 242
• Sector: Consumer Cyclical
• Sector Strength: 84
• Industry: Personal Products & Services
• EPS (TTM): >-0.01
• Shares Outstanding: 400,000,000
• 10 Day Avg. Volume: 6,000
• 30 Day Avg. Volume: 4,666
• PEG Ratio: -0.24
• Price to Book (P/B): 3.17
• Price to Sales (P/S): 1.16
• P/FCF Ratio: 4.18
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 55 Neutral
• Price Target: HK$1.00 ▲(0.00% Upside)

The overall stock score of 55 reflects a mixed outlook. The company's financial performance shows resilience with strong cash flow and improving profitability, but the decline in revenue growth is a concern. Technical analysis suggests potential overbought conditions, and the high P/E ratio indicates overvaluation. These factors combined suggest caution for potential investors.

Positive Factors

Cash Flow Generation

Strong cash flow growth indicates robust financial health, enabling the company to reinvest in business operations and fund strategic initiatives.

Profitability Margins

Improved profitability margins suggest effective cost management, enhancing the company's ability to sustain operations and invest in growth.

Leverage Reduction

Reduced leverage enhances financial stability, providing a buffer against economic fluctuations and increasing financial flexibility.

Negative Factors

Revenue Decline

A decline in revenue growth indicates challenges in market demand or competitive positioning, necessitating strategic adjustments to drive sales.

High Valuation

High valuation may deter potential investors and limit stock price appreciation, impacting long-term investment attractiveness.

Absence of Dividend

Lack of dividends may reduce appeal to income investors, potentially limiting the shareholder base and affecting stock stability.

Miricor Enterprises Holdings Ltd Business Overview & Revenue Model

Company Description

Miricor Enterprises Holdings Ltd (1827) is a diversified investment holding company based in Hong Kong, primarily engaged in the sectors of biotechnology and healthcare. The company focuses on the development, manufacture, and distribution of advanced medical technology and healthcare products, including innovative solutions in the fields of regenerative medicine and cell therapy. Miricor aims to leverage cutting-edge research and development to create products that enhance patient outcomes and address unmet medical needs.

How the Company Makes Money

Miricor Enterprises generates revenue through multiple streams, primarily by commercializing its biotechnology products and services. The company earns money by selling its proprietary medical technologies and healthcare solutions to hospitals, clinics, and other healthcare providers. Additionally, Miricor may engage in partnerships and collaborations with pharmaceutical companies and research institutions, allowing it to share resources, technology, and expertise, which can lead to joint ventures and co-development agreements. This collaborative approach not only expands its market reach but also provides additional funding through shared investments. Furthermore, licensing its technologies and intellectual property to other firms in the biotech sector contributes to its revenue, while government grants and research funding for innovative projects serve as supplementary income sources.

Miricor Enterprises Holdings Ltd Financial Statement Overview

Summary

Miricor Enterprises Holdings Ltd shows strengths in cash flow generation and improving profitability margins. The reduction in leverage and improved return on equity are positive indicators of financial health. However, the decline in revenue growth poses a challenge, requiring strategic initiatives to drive sales.

Income Statement

Miricor Enterprises Holdings Ltd has shown a decline in revenue growth with a negative rate of -11.85% in the latest year, indicating a contraction in sales. However, the company has improved its gross profit margin to 52.37%, suggesting effective cost management. The net profit margin has turned positive at 2.63%, recovering from previous losses, which is a positive sign of profitability. The EBIT and EBITDA margins have also improved, reflecting better operational efficiency.

Balance Sheet

The company's debt-to-equity ratio has decreased to 0.60, indicating a reduction in leverage and a more stable financial structure. Return on equity has improved to 7.18%, showing better utilization of shareholder funds. The equity ratio stands at 31.30%, suggesting a moderate level of equity financing relative to total assets, which provides a cushion against financial risks.

Cash Flow

Miricor Enterprises has achieved a strong free cash flow growth rate of 31.00%, demonstrating improved cash generation capabilities. The operating cash flow to net income ratio is 4.32, indicating robust cash flow relative to net income. The free cash flow to net income ratio is high at 98.29%, reflecting efficient conversion of earnings into cash.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	504.69M	403.15M	494.26M	463.12M	363.92M	128.87M
Gross Profit	247.19M	211.13M	225.37M	238.23M	209.54M	44.99M
EBITDA	121.87M	106.36M	86.62M	70.34M	94.02M	16.93M
Net Income	16.20M	10.59M	-12.62M	-20.50M	25.38M	-12.65M
Balance Sheet
Total Assets	471.28M	471.28M	479.44M	516.81M	476.81M	372.13M
Cash, Cash Equivalents and Short-Term Investments	192.17M	192.17M	182.43M	179.32M	128.16M	161.77M
Total Debt	88.76M	88.76M	99.75M	130.28M	127.58M	42.49M
Total Liabilities	323.72M	323.72M	342.68M	366.10M	305.54M	226.56M
Stockholders Equity	147.56M	147.56M	136.76M	150.71M	171.27M	145.57M
Cash Flow
Free Cash Flow	112.07M	112.07M	58.24M	72.67M	-67.61M	19.07M
Operating Cash Flow	114.02M	114.02M	84.45M	99.45M	44.03M	24.54M
Investing Cash Flow	-46.43M	-30.95M	-59.00M	-37.84M	-97.51M	52.20M
Financing Cash Flow	-74.46M	-50.03M	-55.59M	-21.92M	-28.73M	-14.65M

Miricor Enterprises Holdings Ltd Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 1.00
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1827, the sentiment is Neutral. The current price of 1 is above the 20-day moving average (MA) of 0.98, above the 50-day MA of 0.96, and below the 200-day MA of 1.07, indicating a neutral trend. The MACD of 0.02 indicates Positive momentum. The RSI at 53.74 is Neutral, neither overbought nor oversold. The STOCH value of 58.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:1827.

Miricor Enterprises Holdings Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1161	74 Outperform	$639.72M	7.63	25.63%	5.85%	-1.62%	-10.07%
8603	69 Neutral	HK$2.67B	58.39	49.25%	―	56.28%	-9.91%
1830	66 Neutral	HK$1.75B	8.44	36.52%	11.44%	-23.31%	-44.61%
Sector *	61 Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%
1827	55 Neutral	HK$368.00M	34.72	7.67%	―	-20.59%	―
0919	46 Neutral	€68.74M	―	10.10%	―	-3.40%	512.50%

Miricor Enterprises Holdings Ltd Corporate Events

Miricor Enterprises to Review Interim Results and Dividend Proposal

Miricor Enterprises Holdings Limited has announced that its board of directors will hold a meeting on November 25, 2025, to approve the interim results for the six months ending September 30, 2025. The meeting will also consider the recommendation for an interim dividend payment, which could impact the company’s financial strategy and shareholder returns.

The most recent analyst rating on (HK:1827) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Miricor Enterprises Holdings Ltd stock, see the HK:1827 Stock Forecast page.

Miricor Enterprises Announces Unanimous Approval of AGM Resolutions

Miricor Enterprises Holdings Limited announced the successful passing of all resolutions at its Annual General Meeting held on 29 September 2025. The resolutions included the re-election of directors, re-appointment of auditors, and granting of mandates for share issuance and repurchase, all receiving unanimous support from shareholders.

The most recent analyst rating on (HK:1827) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Miricor Enterprises Holdings Ltd stock, see the HK:1827 Stock Forecast page.

Miricor Enterprises Postpones AGM Due to Typhoon

Miricor Enterprises Holdings Limited has announced the postponement of its Annual General Meeting (AGM) originally scheduled for September 23, 2025, due to an impending typhoon in Hong Kong. The AGM will now take place on September 29, 2025, at the same venue, with all resolutions and proxy arrangements remaining unchanged. This decision ensures the safety of attendees and maintains the integrity of the meeting process.

The most recent analyst rating on (HK:1827) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Miricor Enterprises Holdings Ltd stock, see the HK:1827 Stock Forecast page.